Attributes | Values |
---|
rdf:type
| |
Description
| - Differences in the antioxidant system, apoptotic mechanism and in cell cycle between prostatic cell lines could partially elucidate the development of cisplatin resistance. The aim of this study was to identify the most characteristic parameter for a particular cell line and/or a particular cisplatin treatment using a general regression model and to assess whether it is possible to use measured parameters as markers of cisplatin resistance. This study integrates the results of viability, antioxidant, flow cytometric and quantitative PCR assays in order to characterize the resistance of prostate cancer to cisplatin.
- Differences in the antioxidant system, apoptotic mechanism and in cell cycle between prostatic cell lines could partially elucidate the development of cisplatin resistance. The aim of this study was to identify the most characteristic parameter for a particular cell line and/or a particular cisplatin treatment using a general regression model and to assess whether it is possible to use measured parameters as markers of cisplatin resistance. This study integrates the results of viability, antioxidant, flow cytometric and quantitative PCR assays in order to characterize the resistance of prostate cancer to cisplatin. (en)
|
Title
| - Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
- Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle (en)
|
skos:prefLabel
| - Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
- Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle (en)
|
skos:notation
| - RIV/00216305:26620/14:PU107963!RIV15-MSM-26620___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - I, P(ED1.1.00/02.0068), P(EE2.3.20.0183), P(GAP301/10/0356), V
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216305:26620/14:PU107963
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - prostate cancer, cell cycle, resistance, cisplatin, oxidative stress, (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - INTERNATIONAL JOURNAL OF ONCOLOGY
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Adam, Vojtěch
- Babula, Petr
- Gumulec, Jaromír
- Kizek, René
- Knopfová, Lucia
- Masařík, Michal
- Stiborová, Marie
- Sztalmachová, Markéta
- Tanhäuserová, Veronika
- Ruttkay-Nedecký, Branislav
- Balvan, Jan
- Raudenská, Martina
- Hudcová, Kristýna
- Polanská, Hana
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |